Vitamin k2 mk-7
Vitamin K2 in the menaquinone-7 (MK-7) form is one of the most studied forms of vitamin K2 due to its long half-life and its ability to support the activation (γ-carboxylation) of vitamin K–dependent proteins. Although it is often discussed in relation to bones and arteries, it is also relevant for the intestine and immune system because vitamin K is partly produced/transformed by the microbiota and because signaling mediated by vitamin K–dependent proteins can influence inflammation and tissue integrity.
Fat-soluble vitamin involved in the carboxylation of key proteins for calcium metabolism, vascular health, and immune modulation
Vitamin K2 in the form of menaquinone-7 (MK-7) is one of the most studied forms of vitamin K2 due to its long half-life and its ability to support the activation (γ-carboxylation) of vitamin K–dependent proteins. Although it is often discussed in relation to bones and arteries, it is also relevant for the gut and immune system because vitamin K is partly produced/transformed by the microbiota and because signaling mediated by vitamin K–dependent proteins can influence inflammation and tissue integrity.
Mechanism of action
MK-7 acts as a cofactor in the vitamin K cycle: reduced vitamin K (hydroquinone) enables γ-glutamyl carboxylase to convert specific glutamate residues into γ-carboxyglutamate (Gla) on target proteins. This increases calcium affinity and the functionality of vitamin K–dependent proteins. Vitamin K is then oxidized to the epoxide and regenerated by vitamin K epoxide reductase (VKOR). Effects relevant to the gut and immunity include: (1) potential modulation of inflammatory pathways (associations with CRP and cytokines in some studies), (2) a bidirectional relationship with the microbiota (microbial production of menaquinones and the impact of dysbiosis/antibiotics on vitamin K status), (3) a possible role in tissue protection through Gla proteins expressed in various tissues, although clinical evidence remains inconclusive for specific immune outcomes.
Supported benefits
- Improvement in vitamin K status (reduction of uncarboxylated vitamin K–dependent proteins, e.g. ucMGP and/or uncarboxylated osteocalcin) with MK-7 supplementation (strong)
- Support for bone health (bone turnover markers and, in some studies, density/mineralization parameters), especially in specific populations and with longer follow-up (moderate)
- Possible support for vascular health (markers of calcification/arterial elasticity in some studies; heterogeneous results on hard clinical endpoints) (moderate)
- Associations with lower systemic inflammation (markers such as CRP) and potential immune modulation; direct clinical evidence on immune outcomes is still limited (limited)
- Relevance in contexts of dysbiosis, fat malabsorption, or antibiotic use (risk of reduced vitamin K status); specific data on MK-7 for clinical intestinal outcomes are still emerging (emerging)
Safety & side effects
- Generally well tolerated at studied doses; mild gastrointestinal disturbances (e.g. nausea, discomfort) are possible in a minority of individuals
- Hypersensitivity reactions are rare but possible (also depending on excipients)
- In predisposed individuals, changes in coagulation are mainly relevant in the presence of vitamin K antagonist anticoagulant therapy
FAQ
Is MK-7 different from vitamin K1 and MK-4?
Yes. K1 (phylloquinone) is predominant in leafy greens and has different kinetics; MK-4 is a form of K2 found in some animal foods and can result from tissue conversion. MK-7, typical of fermented foods such as natto, tends to have a longer half-life and more stable plasma levels with daily intake.
What is the connection between vitamin K2 and the gut?
Some gut bacteria can produce menaquinones, and a fermented diet can provide MK-7. Dysbiosis, antibiotics, or fat malabsorption can reduce vitamin K status. However, the amount of vitamin K produced in the colon that is actually usable by the body is still debated and may vary.
Does vitamin K2 “strengthen” the immune system?
The strongest evidence concerns the activation of vitamin K–dependent proteins and related markers. For clinical immune outcomes (e.g. reduction in infections), data are limited; some studies observe associations with inflammatory markers, but they are not conclusive.
Why is vitamin D discussed together with K2?
Vitamin D may increase the expression of some proteins involved in calcium metabolism; vitamin K contributes to their activation through carboxylation. This is a biological rationale, but it does not automatically imply that the combination is necessary or appropriate for everyone.
Who should pay particular attention to vitamin K2?
Those taking vitamin K antagonist anticoagulants, those with clotting disorders, those with fat malabsorption or liver-biliary/pancreatic diseases, and those with complex clinical conditions: in these cases, any change in vitamin K intake should be managed by a professional.
The information provided is for informational and educational purposes only. It does not constitute medical advice. Use should be assessed and authorized by a qualified healthcare professional.
Mechanism of action
MK-7 acts as a cofactor in the vitamin K cycle: reduced vitamin K (hydroquinone) enables γ-glutamyl carboxylase to convert specific glutamate residues into γ-carboxyglutamate (Gla) on target proteins. This increases calcium affinity and the functionality of vitamin K–dependent proteins. Vitamin K is then oxidized to epoxide and regenerated by vitamin K epoxide reductase (VKOR). Relevant effects for the intestine and immunity include: (1) potential modulation of inflammatory pathways (associations with CRP and cytokines in some studies), (2) a bidirectional relationship with the microbiota (microbial production of menaquinones and the impact of dysbiosis/antibiotics on K status), (3) a possible role in tissue protection through Gla proteins expressed in various tissues, although clinical evidence is still not definitive for specific immune outcomes.
Scientific benefits
Contraindications
- Therapy with vitamin K antagonists (e.g. warfarin): vitamin K2 may interfere with the anticoagulant effect; requires medical management
- History of thrombotic events or clotting disorders: clinical evaluation is necessary before any change in vitamin K intake
- Severe fat malabsorption or hepato-biliary/pancreatic diseases: supplementation and monitoring must be managed by professionals
- Pregnancy and breastfeeding: specific data on MK-7 as a supplement are limited; professional evaluation recommended
Side effects
- Generally well tolerated at studied doses; possible mild gastrointestinal disturbances (e.g. nausea, discomfort) in a minority of subjects
- Hypersensitivity reactions are rare but possible (also depending on excipients)
- In predisposed individuals, changes in coagulation are mainly relevant in the presence of vitamin K antagonist anticoagulant therapy
Interactions
- Vitamin K antagonist anticoagulants (warfarin and similar): clinically significant interaction (reduction of INR/anticoagulant effect)
- Broad-spectrum antibiotics: may reduce microbial production of menaquinones and alter vitamin K status; the effect varies
- Bile acid sequestrants (e.g. cholestyramine/colesevelam) and orlistat: may reduce the absorption of fat-soluble vitamins
- High doses of vitamin E: may interfere with vitamin K in some contexts (evidence and clinical relevance vary)
Regulatory status
Marketed as a dietary supplement in many areas (EU/USA and other countries) with specific rules on purity, doses, novel food/ingredient status, and claims. Permitted health claims vary by jurisdiction; in the EU there are authorized claims for vitamin K in relation to normal blood clotting and the maintenance of normal bones (referring to vitamin K in general, not necessarily specific to MK-7).
Supplements and peptides
Intestine and Immune SystemAstragalus
Astragalus is a plant used in herbal medicine (especially in traditional Chinese medicine) to support the immune…
Intestine and Immune SystemBeta glucans
Beta-glucans are soluble fibers made up of glucose chains with β bonds (mainly β-1,3/β-1,6 in yeasts and fungi; β-1,3…
Intestine and Immune SystemZinc carnosine
Zinc carnosine is a stable complex of zinc and L-carnosine, developed to adhere to the gastric mucosa and locally…